ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, featuring promising improvements throughout several medical and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA gives a safer, extra responsible alternate for therapeutic use, significantly